Literature DB >> 22840284

Zoonotic pathogens among white-tailed deer, northern Mexico, 2004-2009.

Citlaly Medrano, Mariana Boadella, Hugo Barrios, Antonio Cantú, Zeferino García, José de la Fuente, Christian Gortazar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22840284      PMCID: PMC3414034          DOI: 10.3201/eid1808.111902

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Intense wildlife management for hunting affects risks associated with zoonotic pathogens (). White-tailed deer (Odocoileus virginianus) are increasingly managed by fencing, feeding, watering, and translocation to increase incomes from hunting in northern Mexico (). These deer also play a major role in dissemination and reintroduction of pathogens and vectors from Mexico into the United States (,). White-tailed deer are suitable reservoir hosts for Mycobacterium bovis (), and an M. bovis-positive white-tailed deer was recently found in Tamaulipas in northeastern Mexico (). Brucellosis is widespread in many animal hosts in Latin America () and thus of interest in white-tailed deer. Another major zoonosis, sometimes linked to raw deer meat consumption, is hepatitis E, which is caused by genotypes of hepatitis E virus (HEV) (). HEV is increasingly prevalent in red deer (Cervus elaphus) (), but its prevalence in white-tailed deer is unknown. The objective of this study was to determine the prevalence of zoonotic pathogens in white-tailed deer in northern Mexico. This study was conducted under a scientific collecting permit issued by the Mexican Division of Animal and Wildlife Health and on 8 ranches in 3 states in northern Mexico (≈26–28°N, 99–100°W). Serum samples (n = 347) were collected during 2004–2009 in a cross-sectional survey for antibodies against HEV, Brucella spp., and mycobacteria. Deer were opportunistically sampled during live-capture operations as described by Cantú et al. (). Bleeding was performed by using jugular venipuncture and vacuum tubes without anticoagulant. Samples were allowed to clot and centrifuged to collect serum that was stored at −20°C. Serum samples were tested for IgG against HEV by ELISA as described (). Serum samples were also tested for antibodies against Brucella spp. by using a commercial ELISA (Ingezim Brucella Compac 2.0 Ingenasa, Madrid, Spain), according to the manufacturer’s instructions. Detection of antibodies cross-reacting with 2 widely used mycobacterial antigens, bovine purified protein derivative (PPD) and paratuberculosis protoplasmatic antigen 3 (PPA3), was conducted as described (). The sensitivity and specificity of this assay have not been established for white-tailed deer, but it has been used in seroprevalence studies of wild boar and fallow deer (,). Insufficient volumes of serum samples prevented testing for antibodies against all pathogens (Table). Limited serum volume and lack of other (organ) samples also precluded additional analyses to verify presence of pathogens.
Table

Prevalence of serum antibodies against zoonotic pathogen antigens among white-tailed deer on 8 ranches, northern Mexico, 2004–2009*

Ranch no.StateMunicipalitySample sizeNo. positive/no. tested (%)
HEVBrucella spp.Bovine PPDPPA3
1TamaulipasGuerrero10/1 (0)0/1 (0)0/1 (0)0/1 (0)
2TamaulipasGuerrero10641/71 (57.7)0/102 (0)9/102 (8.8)0/102 (0)
3TamaulipasNuevo Laredo3721/27 (77.7)00/37 (0)0/37 (0)
4Nuevo LeónUnknown35003/35 (8.5)2/35 (5.7)
5CoahuilaGuerrero351/1 (100)0/33 (0)2/33 (6.0)1/33 (3.0)
6CoahuilaGuerrero506/17 (35.2)0/40 (0)3/40 (7.5)0/40 (0)
7CoahuilaHidalgo174/6 (66.6)1/16 (6.2)3/16 (18.7)5/16 (31.2)
8CoahuilaGuerrero6616/19 (84.2)0/39 (0)7/39 (18.0)0/39 (0)
NATotalNA34789/142 (62.7)1/231 (0.4)27/303 (8.9)8/303 (2.6)

*HEV, hepatitis E virus; PPD, purified protein derivative; PPA3, paratuberculosis protoplasmatic antigen 3; NA, not applicable.

*HEV, hepatitis E virus; PPD, purified protein derivative; PPA3, paratuberculosis protoplasmatic antigen 3; NA, not applicable. Prevalence was 62.7% (95% CI 54%–70%) for antibodies against HEV, 0.4% (95% CI 0%–2%) for antibodies against Brucella spp., 8.9% (95% CI 6%–13%) for antibodies against bovine PPD, and 2.6% (95% CI 1%–5%) for antibodies against PPA3 (Table). Antibody responses to bovine PPD were detected in deer from at 6 of 8 sampling sites; in deer from 3 of these sites, antibodies were also detected against PPA3 antigen. Seroprevalence against bovine PPD was higher than that against PPA3 (χ2 10.9, df 1, p<0.01). This cross-sectional survey of white-tailed deer in northern Mexico detected antibodies to several pathogens relevant to public and animal health. High prevalence of antibodies against HEV and frequent detection of antibodies against mycobacterial antigens are public health concerns. Prevalence of antibodies against HEV were 3× higher than that reported for red deer in Europe (). This result suggests wide circulation of HEV in the study region and warrants further research, including detection and sequencing of virus RNA. Low Brucella spp. antibody prevalence confirms results of a study in this region (). Antibody responses to bovine PPD were detected in serum samples from deer from most sampling sites, occasionally in the absence of antibodies against PPA3. These results, and a recent report of an M. bovis–positive white-tailed deer from this region (), suggest that these deer may be contracting M. bovis in northern Mexico. If one considers that white-tailed deer are M. bovis reservoirs in other parts of North America and that risk factors such as supplemental feeding are present in northern Mexico, there is a high risk for pathogen transmission to animals and humans (). White-tailed deer are probably exposed to several human pathogens that are relevant to human and animal health in northern Mexico. Although this cross-sectional survey provided only an indication of pathogen prevalence in the study populations, high antibody prevalence to HEV and mycobacterial antigens requires antigen-targeted surveillance. Risks associated with pathogen translocation by white-tailed deer are also relevant to neighboring states in Mexico and the United States.
  9 in total

1.  Performance of immunochromatographic and ELISA tests for detecting fallow deer infected with Mycobacterium bovis.

Authors:  M Boadella; J A Barasona; S Diaz-Sanchez; K P Lyashchenko; R Greenwald; J Esfandiari; C Gortazar
Journal:  Prev Vet Med       Date:  2011-11-08       Impact factor: 2.670

2.  Identification of genotype 3 hepatitis E virus (HEV) in serum and fecal samples from pigs in Thailand and Mexico, where genotype 1 and 2 HEV strains are prevalent in the respective human populations.

Authors:  K Cooper; F F Huang; L Batista; C D Rayo; J C Bezanilla; T E Toth; X J Meng
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Evaluation of the influence of supplemental feeding of white-tailed deer (Odocoileus virginianus) on the prevalence of bovine tuberculosis in the Michigan wild deer population.

Authors:  RoseAnn Miller; John B Kaneene; Scott D Fitzgerald; Steven M Schmitt
Journal:  J Wildl Dis       Date:  2003-01       Impact factor: 1.535

Review 4.  Evidence for role of white-tailed deer (Artiodactyla: Cervidae) in epizootiology of cattle ticks and southern cattle ticks (Acari: Ixodidae) in reinfestations along the Texas/Mexico border in south Texas: a review and update.

Authors:  J M Pound; J E George; D M Kammlah; K H Lohmeyer; R B Davey
Journal:  J Econ Entomol       Date:  2010-04       Impact factor: 2.381

5.  One Health approach to identify research needs in bovine and human babesioses: workshop report.

Authors:  Adalberto A Pérez de León; Daniel A Strickman; Donald P Knowles; Durland Fish; Eileen Thacker; José de la Fuente; Peter J Krause; Stephen K Wikel; Ryan S Miller; Gale G Wagner; Consuelo Almazán; Robert Hillman; Matthew T Messenger; Paul O Ugstad; Roberta A Duhaime; Pete D Teel; Alfonso Ortega-Santos; David G Hewitt; Edwin J Bowers; Stephen J Bent; Matt H Cochran; Terry F McElwain; Glen A Scoles; Carlos E Suarez; Ronald Davey; Jeanne M Howell Freeman; Kimberly Lohmeyer; Andrew Y Li; Felix D Guerrero; Diane M Kammlah; Pamela Phillips; Joe M Pound
Journal:  Parasit Vectors       Date:  2010-04-08       Impact factor: 3.876

6.  Serologic tests for detecting antibodies against Mycobacterium bovis and Mycobacterium avium subspecies paratuberculosis in Eurasian wild boar (Sus scrofa scrofa).

Authors:  Mariana Boadella; Konstantin Lyashchenko; Reena Greenwald; Javan Esfandiari; Raquel Jaroso; Tania Carta; Joseba M Garrido; Joaquín Vicente; José de la Fuente; Christian Gortázar
Journal:  J Vet Diagn Invest       Date:  2011-01       Impact factor: 1.279

7.  Prevalence of infectious agents in free-ranging white-tailed deer in northeastern Mexico.

Authors:  Antonio Cantu; J Alfonso Ortega-S; Juan Mosqueda; Zeferino Garcia-Vazquez; Scott E Henke; John E George
Journal:  J Wildl Dis       Date:  2008-10       Impact factor: 1.535

8.  Brucella isolated in humans and animals in Latin America from 1968 to 2006.

Authors:  N E Lucero; S M Ayala; G I Escobar; N R Jacob
Journal:  Epidemiol Infect       Date:  2007-06-11       Impact factor: 2.451

9.  Increasing contact with hepatitis E virus in red deer, Spain.

Authors:  Mariana Boadella; Maribel Casas; Marga Martín; Joaquín Vicente; Joaquim Segalés; José de la Fuente; Christian Gortázar
Journal:  Emerg Infect Dis       Date:  2010-12       Impact factor: 6.883

  9 in total
  10 in total

Review 1.  Mycobacterium bovis (bovine tuberculosis) infection in North American wildlife: current status and opportunities for mitigation of risks of further infection in wildlife populations.

Authors:  R S Miller; S J Sweeney
Journal:  Epidemiol Infect       Date:  2013-05-09       Impact factor: 4.434

2.  Introduction to this issue: Dealing with TB in wildlife.

Authors:  C Gortazar; P Cowan
Journal:  Epidemiol Infect       Date:  2013-07       Impact factor: 4.434

Review 3.  Hepatitis E virus: foodborne, waterborne and zoonotic transmission.

Authors:  Danielle M Yugo; Xiang-Jin Meng
Journal:  Int J Environ Res Public Health       Date:  2013-09-25       Impact factor: 3.390

Review 4.  Pathogenic Landscape of Transboundary Zoonotic Diseases in the Mexico-US Border Along the Rio Grande.

Authors:  Maria Dolores Esteve-Gassent; Adalberto A Pérez de León; Dora Romero-Salas; Teresa P Feria-Arroyo; Ramiro Patino; Ivan Castro-Arellano; Guadalupe Gordillo-Pérez; Allan Auclair; John Goolsby; Roger Ivan Rodriguez-Vivas; Jose Guillermo Estrada-Franco
Journal:  Front Public Health       Date:  2014-11-17

Review 5.  Hepatitis E: A disease of reemerging importance.

Authors:  Siddharth Sridhar; Susanna K P Lau; Patrick C Y Woo
Journal:  J Formos Med Assoc       Date:  2015-03-12       Impact factor: 3.282

Review 6.  The Foodborne Transmission of Hepatitis E Virus to Humans.

Authors:  Samantha Treagus; Conal Wright; Craig Baker-Austin; Ben Longdon; James Lowther
Journal:  Food Environ Virol       Date:  2021-03-18       Impact factor: 2.778

7.  Zoonotic diseases appeared to be a major hurdle to successful deer farming in Bangladesh.

Authors:  Sajeda Sultana; Nazneen Sultana; Mahmuda Islam; Munmun Pervin; Md Ariful Islam Khan; Mohammad Abu Hadi Noor Ali Khan
Journal:  Vet World       Date:  2021-09-22

Review 8.  Recent knowledge on hepatitis E virus in Suidae reservoirs and transmission routes to human.

Authors:  Nicole Pavio; Virginie Doceul; Eugénie Bagdassarian; Reimar Johne
Journal:  Vet Res       Date:  2017-11-21       Impact factor: 3.683

Review 9.  Diseases at the livestock-wildlife interface: status, challenges, and opportunities in the United States.

Authors:  Ryan S Miller; Matthew L Farnsworth; Jennifer L Malmberg
Journal:  Prev Vet Med       Date:  2012-12-14       Impact factor: 2.670

10.  Antibodies Against Hepatitis E Virus (HEV) in European Moose and White-Tailed Deer in Finland.

Authors:  Emil Loikkanen; Satu Oristo; Natalia Hämäläinen; Pikka Jokelainen; Tuija Kantala; Antti Sukura; Leena Maunula
Journal:  Food Environ Virol       Date:  2020-09-07       Impact factor: 2.778

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.